Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca completes sale of Aptium Oncology assets
-
Bristol-Myers Squibb and AstraZeneca expand diabetes alliance through Bristol-Myers Squibb’s acquisition of Amylin Pharmaceuticals
-
AstraZeneca and Merck agree to amend second option
-
Zinforo (ceftaroline fosamil) receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia
-
New data show investigational compound dapagliflozin demonstrated significant reductions in blood sugar levels when added to sitagliptin in adults with type 2 diabetes at 24 weeks, with results maintained over 48 weeks
-
Innovative public-private collaboration launches to tackle antibiotic research
-
AstraZeneca PLC First quarter results 2012
-
David Brennan to retire as AstraZeneca’s Chief Executive Officer
-
AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
-
AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout
Latest articles and press releases
All of our latest press releases and articles are available to explore
